COVID-19: mortalidade aumenta mas letalidade diminui

COVID-19: mortalidade aumenta mas letalidade diminui: Os dados da DGS sobre a evolução da pandemia de COVID-19 mostram que, embora a taxa de mortalidade da doença esteja a aumentar, a taxa de letalidade tem diminuído.

Até este momento (situação até dia 1 de novembro de 2020), foram registados um total de 146 847 casos confirmados da doença em Portugal. Destes, 83 294 (ou seja, 57%), já recuperou, havendo um total de 2590 óbitos, o que equivale a 1.8% do total de infetados.

Na mesma data, existiam 2255 internados nos hospitais do SNS, dos quais 294 em Unidades de Cuidados intensivos. O número de internados corresponde a 1.5% do número de infetados e os que necessitam UCI representam 13% daqueles.

The Riddle of Sweden's COVID-19 Numbers

The Riddle of Sweden's COVID-19 Numbers | Fantastic Anachronism: Comparing Sweden's COVID-19 statistics to other European countries, two peculiar features emerge: 

Despite very different policies, Sweden has a similar pattern of cases. 

Despite a similar pattern of cases, Sweden has a very different pattern of deaths.

 

The science of superspreading

The science of superspreading: Why preventing hot spots of transmission is key to stopping the COVID-19 pandemic

What you need to know about the coronavirus pandemic on 3 November

COVID-19: What you need to know about the coronavirus pandemic on 3 November: Top stories: Spain sets record one-day case increase; hope for 'cellular immunity'; WHO advises countries to invest in basics.

Masks Work. Really. We’ll Show You How

Masks Work. Really. We’ll Show You How

 

The process for creating a COVID-19 vaccine may be different from other common vaccines

A COVID-19 vaccine may be different from others, Andrea Amalfitano says.

Amalfitano is dean of the Michigan State University College of Osteopathic Medicine and a professor of pediatrics, microbiology, and molecular genetics.

Q - What information hasn’t the media covered that you feel is important about a COVID-19 vaccine?

A -I think the fact that the ability to scale up any new vaccine is not a given. In fact, I am always dismayed when individual researchers or companies tout a new finding in the laboratory as the next great therapy, without any indication or proof that the therapy is safe in large populations or can even be safely produced to be given to large populations.

 

As a clinician, I many times have had to tell patients these realities when they encounter the latest news on the next great medical breakthrough. This reality check can many times be devastating to someone affected with, for example, a life-threatening illness or condition. You can imagine in my field of clinical genetics I see this often, as many genetic conditions can be lethal. I have found that false hope can be devastating to individuals and shake their faith in the science of medical therapeutic development. This to me is a tragedy, for if the public loses faith in our ability as scientists to not “overexaggerate,” they may not support our efforts in the future.

What you need to know about the coronavirus pandemic on 2 November

COVID-19: What you need to know about the coronavirus pandemic on 2 November: Top stories: New lockdown in England, 'natural herd immunity warning', Australia reports no new cases.